Cognitive Function After Treatment of Primary CNS Malignancy
Status
Conditions
Study type
Funder types
Identifiers
Details and patient eligibility
About
In this study, the investigators propose to evaluate cognitive function and determine the feasibility of neurocognitive assessment using a select CogState test battery in patients with primary intracranial malignancies receiving photon- or proton-based cranial irradiation with curative intent. The investigators will use the CogState software to quantify changes in verbal learning, memory, and executive function over the initial months and years following radiation treatment. Cognitive changes and temporal patterns of function will be compared to baseline performance for each patient. Data regarding cognitive function, fatigue, quality of life, and standard patient reported outcomes will be collected to characterize the daily impact of treatment. In addition, observed outcomes will be correlated with dosimetry values, radiation dose volumes, and anatomic dose distribution.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Age ≥ 4 years with primary CNS malignancy
- Able to use computer for assessment battery
- Receiving photon- or proton-based radiation for primary intracranial malignancy
- Demonstrates the capacity to sign informed consent
Exclusion criteria
- Patients with WHO Grade IV tumors
Trial contacts and locations
Loading...
Central trial contact
Clinical Trials Referral Office
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal